Precision medicine delivers personalized cancer care based on an individual’s genomics, lifestyle, and environment. Precision medicine implements the use of biomarkers, molecular testing, and targeted therapies to tailor treatment plans that address the unique needs of every patient.
Helping to bring personalized cancer care into focus, ACCC transforms complex science into clear and actionable education that brings clarity to patient care decisions. From essential knowledge on cancer screening updates to clinically impactful biomarker testing and new cancer diagnostic assay development, the ACCC Precision Medicine Library has fundamental resources that match the professional needs and preferred learning styles of the multidisciplinary cancer team.
ACCC develops targeted educational resources and programs that help multidisciplinary cancer care teams stay up to date on the latest advancements in cancer diagnostics. This includes resources on subjects including biomarkers, measurable residual disease (MRD) testing, multi-cancer early detection, and pathology.
ACCC develops targeted educational resources and programs that help multidisciplinary cancer care teams stay up to date on the latest advancements in cancer diagnostics. This includes resources on subjects including biomarkers, measurable residual disease (MRD) testing, multi-cancer early detection, and pathology.
ACCC offers a variety of educational and practical resources to help community programs achieve a more coordinated care experience for their patients. This includes projects and resources on eliminating disparities in precision medicine, genetic counseling, and precision medicine stewardship.
Tumor Treating Fields (TTFields) therapy is FDA-approved for several cancers, including newly diagnosed glioblastoma, but uptake remains variable. Based on interviews with three cancer programs that offer TTFields, this ACCC guide explains how they built buy-in across the care team, prepared patients and caregivers, and set up clear communication pathways. It also includes practical recommendations for care teams, patients, and caregivers to support patients throughout therapy.
By championing and encouraging advanced practice providers and allied health professionals to work at the top of their licenses, Wilmot Cancer Institute offers comprehensive care close to home through its breast care program that vastly improves the patient experience.
Recognizing the critical role advanced practice providers and allied health professionals play in the care continuum, the American Oncology Network provides infrastructure, leadership, and professional growth opportunities to empower these members of the cancer care team to practice at the top of their license.
A recent ACCC video series with three cancer programs centered on how Tumor Treating Fields (TTFields) therapy can be integrated into everyday practice without overwhelming clinical or administrative teams or the patients they care for.
ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.
In this episode, CANCER BUZZ speaks with Erin Pierce, MSN, APRN, FNP-C, Associate Clinical Investigator and Nurse Practitioner at HonorHealth Research Institute, and Kristen Kipping-Johnsson, MPH, Director of Network Research Operations at the University of Chicago, about how each of their cancer programs are approaching DCT implementation. Their discussion explores how decentralized components, such as community-based treatment delivery, centralized research infrastructure, and hybrid trial designs, can increase participation opportunities for patients in both community and academic settings.
In this episode, CANCER BUZZ explores how it feels physically and emotionally for patients to begin and continue BsAb therapy. Grounded in real-world insights, this discussion highlights the logistical and emotional challenges that arise during the step-up period and early treatment phases and identifies opportunities for care teams to better support patients throughout their journey.
In this episode, CANCER BUZZ speaks with Manojkumar Bupathi, MD, President of Rocky Mountain Cancer Centers, about how ADCs are reshaping the care model toward earlier, structured collaboration between urology and medical oncology.
In this episode, CANCER BUZZ speaks with Terence Friedlander, MD, and Iva Petrovchich Colón, NP, both part of the team treating bladder cancer at the University of California, San Francisco (UCSF), about how their cancer program manages the toxicity profile of ADCs in order to prioritize patient outcomes and quality of life.
Gain insights on reshaping multidisciplinary cancer care team workflows to enable laboratory professionals to improve biomarker testing efficiency.
While recent advances in precision medicine have substantially changed the management of lung cancer, care must be taken to ensure that these advances do not worsen health disparities. This study included a case component that divided overall respondents into two cohorts to observe how patient characteristics, such as age, socio-economic status, race/ethnicity, and health literacy, affected the likelihood of ordering biomarker testing.
This article explores the exciting potential for pharmacists in the cardio-oncology setting, where their knowledge of oncolytic therapies, drug interactions, and toxicity management proves integral to patient care.
ACCC shares how Sanford Health introduced its own “precision medicine steward” through the development of a pilot Oncology Nurse Navigator, Genomics (ONNG) role, which has improved coordination of its biomarker testing program.
Presented at The American Society for Clinical Pathology (ASCP) 2022 Annual Meeting, September 7-9, 2022.
Presented at the 2021 ASCO Quality Care Symposium, September 24 - 25, 2021.
Presented at the IASLC 2021 World Conference on Lung Cancer, September 8-14, 2021
Presented at the SITC Annual Conference.